KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Change in Cash (2016 - 2025)

Historic Change in Cash for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $560.0 million.

  • Abbott Laboratories' Change in Cash fell 192.64% to $560.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$47.0 million, marking a year-over-year decrease of 10553.59%. This contributed to the annual value of $720.0 million for FY2024, which is 12411.25% up from last year.
  • Abbott Laboratories' Change in Cash amounted to $560.0 million in Q3 2025, which was down 192.64% from $419.0 million recorded in Q2 2025.
  • Abbott Laboratories' Change in Cash's 5-year high stood at $1.3 billion during Q2 2022, with a 5-year trough of -$2.1 billion in Q1 2022.
  • In the last 5 years, Abbott Laboratories' Change in Cash had a median value of $419.0 million in 2025 and averaged $35.4 million.
  • As far as peak fluctuations go, Abbott Laboratories' Change in Cash soared by 35175.98% in 2021, and later crashed by 27467.11% in 2022.
  • Quarter analysis of 5 years shows Abbott Laboratories' Change in Cash stood at $497.0 million in 2021, then plummeted by 42.05% to $288.0 million in 2022, then crashed by 35.07% to $187.0 million in 2023, then plummeted by 68.98% to $58.0 million in 2024, then surged by 865.52% to $560.0 million in 2025.
  • Its Change in Cash was $560.0 million in Q3 2025, compared to $419.0 million in Q2 2025 and -$1.1 billion in Q1 2025.